Screening for anal cancer in women

Journal of Lower Genital Tract Disease

Volumn 19, Issue 3, 2015, Pages S27-S42

  Moscicki, Anna Barbara ^a   Darragh, Teresa M ^b   Michael Berry Lawhorn, J ^b   Roberts, Jennifer M ^c   Khan, Michelle J ^d   Boardman, Lori A ^e   Chiao, Elizabeth ^f   Einstein, Mark H ^g   Goldstone, Stephen E ^h   Jay, Naomi ^b   Likes, Wendy M ⁱ   Stier, Elizabeth A ^j   Welton, Mark L ^k   Wiley, Dorothy J ^l   Palefsky, Joel M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Douglass Hanly Moir Pathology   (Australia)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^f MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^j BOSTON MEDICAL CENTER   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; ANUS CARCINOMA; ARTICLE; AUTOIMMUNE DISEASE; CANCER RISK; COLPOSCOPY; CYTOLOGY; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; FEMALE GENITAL TRACT CANCER; HEMATOLOGIC MALIGNANCY; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INFLAMMATORY BOWEL DISEASE; MEDICAL SOCIETY; META ANALYSIS; ORGAN TRANSPLANTATION; PAPILLOMAVIRUS INFECTION; SYSTEMATIC REVIEW; ANUS NEOPLASMS; COMPLICATION; EARLY CANCER DIAGNOSIS; FEMALE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; RISK FACTOR; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX;

ANUS NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX;

EID: 84991501365     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0000000000000117     Document Type: Article

References (126)

1. American Cancer Society. Anal Cancer: Key Statistics. 2015; http://www. cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-keystatistics. Accessed March 1, 2015.
2. National Cancer Institute. SEER Cancer Statistics Factsheets: Anal Cancer. 2014; http://seer.cancer.gov/statfacts/html/anus.html. Accessed May 27, 2014.
3. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30(suppl 5):F12-23.
4. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24(suppl 3):S11-25.
5. Abramowitz L, Jacquard AC, Jaroud F, et al. Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study. Int J Cancer 2011;129:433-9.
6. Einstein MH, Burk RD. Persistent human papillomavirus infection: definitions and clinical Implications. Papillomavirus Report 2001;12: 119-23.
7. Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer. Obstet Gynecol 2010;116:177-85.
8. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol 2008;9:425-34.
9. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
10. Hernandez BY, McDuffie K, Zhu X, et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005;14((11 Pt 1)): 2550-6.
11. Schlecht NF, Burk RD, Nucci-Sack A, et al. Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations. PLoS One 2012;7:e37419.
12. Castro FA, Quint W, Gonzalez P, et al. Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis 2012;206:1103-10.
13. Goodman MT, Shvetsov YB, McDuffie K, et al. Acquisition of anal human papillomavirus (HPV) infection in women: The Hawaii HPV Cohort study. J Infect Dis 2008;197:957-66.
14. Goodman MT, Shvetsov YB, McDuffie K, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: The Hawaii HPV Cohort Study. J Infect Dis 2010;201:1331-9.
15. Goodman MT, McDuffie K, Hernandez BY, et al. The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: The Hawaii HPV cohort study. J Infect Dis 2011;203:335-40.
16. Shvetsov YB, Hernandez BY, McDuffie K, et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: The Hawaii HPV cohort study. Clin Infect Dis 2009;48:536-46.
17. Moscicki AB, Ma Y, Farhat S, et al. Natural history of anal human papillomavirus infection in heterosexualwomen and risks associated with persistence. Clin Infect Dis 2014;58:804-11.
18. MoscickiAB, Durako SJ, Houser J, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003;17:311-20.
19. Hessol NA, Holly EA, Efird JT, et al. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009;23:59-70.
20. Moscicki AB, Hills NK, Shiboski S, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999;8:173-8.
21. Koppe DC, Bandeira CB, Rosa MR, et al. Prevalence of anal intraepithelial neoplasia in women with genital neoplasia. Dis Colon Rectum 2011;54:442-5.
22. Jacyntho CM, Giraldo PC, Horta AA, et al. Association between genital intraepithelial lesions and anal squamous intraepithelial lesions in HIV-negative women. Am J Obstet Gynecol 2011;205:115 e111-115.
23. Stanley MA, Sterling JC. Host responses to infection with human papillomavirus. Curr Probl Dermatol 2014;45:58-74.
24. Briggaman RA, Wheeler CE Jr. Immunology of human warts. J AmAcad Dermatol 1979;1:297-304.
25. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-Associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92: 1500-10.
26. Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012;54:1026-34.
27. Chiao EY, Krown SE, Stier EA, et al. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIVepidemic. J Acquir Immune Defic Syndr (1999) 2005;40: 451-5.
28. Yanik EL, Tamburro K, Eron JJ, et al. Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer 2013;8:18.
29. Simard EP, Pfeiffer RM, Engels EA. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011;117:1089-96.
30. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2551-9.
31. Lanoy E, Spano JP, Bonnet F, et al. The spectrum of malignancies in HIV-infected patients in 2006 in France: The ONCOVIH study. Int J Cancer 2011;129:467-75.
32. Piketty C, Selinger-Leneman H, Bouvier AM, et al. Incidence of HIV-related anal cancer remains increased despite long-Term combined antiretroviral treatment: results from the French hospital database on HIV. J Clin Oncol 2012;30:4360-6.
33. Guiguet M, Boue F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individualmalignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet Oncol 2009;10: 1152-9.
34. Franzetti M, Adorni F, Parravicini C, et al. Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: A single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr (1999) 2013;62:414-20.
35. Vogel M, Friedrich O, Luchters G, et al. Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res 2011;16:101-7.
36. Hou JY, Smotkin D, Grossberg R, et al. High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer. J Acquir Immune Defic Syndr (1999) 2012;60:169-72.
37. Gingelmaier A, Weissenbacher T, Kost B, et al. Anal cytology as a screening tool for early detection of anal dysplasia in HIV-infected women. Anticancer Res 2010;30:1719-23.
38. Chaves EB, Folgierini H, Capp E, et al. Prevalence of abnormal anal cytology in women infected with HIV. J Med Virol 2012;84:1335-9.
39. Tandon R, Baranoski AS, Huang F, et al. Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol 2010;203:21 e21-26.
40. Gaisa M, Sigel K, Hand J, et al. High rates of anal dysplasia in HIV-infected men who have sex withmen, women, and heterosexual men. AIDS 2014;28:215-22.
41. Williams AB, Darragh TM, Vranizan K, et al. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-11.
42. Durante AJ, Williams AB, Da CostaM, et al. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 2003;12:638-42.
43. Holly EA, Ralston ML, Darragh TM, et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-9.
44. Hessol NA, Holly EA, Efird JT, et al. Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS 2013;27:1743-51.
45. Baranoski AS, Tandon R, Weinberg J, et al. Risk factors for abnormal anal cytology over time in HIV-infected women. Am J Obstet Gynecol 2012; 207:107 e101-108.
46. Weis SE, Vecino I, Pogoda JM, et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011;54:433-41.
47. Likes W, Santoso JT, Wan J. A cross-sectional analysis of lower genital tract intraepithelial neoplasia in immune-compromised women with an abnormal Pap. Arch Gynecol Obstet 2013;287:743-7.
48. Mallari AO, Schwartz TM, Luque AE, et al. Anal cancer screening in HIV-infected patients: is it time to screen them all? Dis Colon Rectum 2012;55:1244-50.
49. Tatti S, Suzuki V, Fleider L, et al. Anal intraepithelial lesions in women with human papillomavirus-related disease. J Low Genit Tract Dis 2012; 16:454-9.
50. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions inmen who have sex with men: A systematic review and meta-Analysis. Lancet Oncol 2012;13:487-500.
51. Kojic EM, Cu-Uvin S, Conley L, et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis 2011;38:253-9.
52. Palefsky JM, Holly EA, RalstonML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negativewomen. J Infect Dis 2001;183: 383-91.
53. Beachler DC, D'Souza G, Sugar EA, et al. Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis 2013;208: 330-9.
54. MadeleineMM, Finch JL, Lynch CF, et al. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013;13: 3202-9.
55. Mitsuishi T, Iwabu Y, Tokunaga K, et al. Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors. BMC Cancer 2010;10:118.
56. Sunesen KG, Norgaard M, Thorlacius-Ussing O, et al. Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978-2005. Int J Cancer 2010;127: 675-84.
57. Busnach G, Piselli P, Arbustini E, et al. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc 2006;38:3533-5.
58. Ogilvie JW Jr, Park IU, Downs LS, et al. Anal dysplasia in kidney transplant recipients. J Am Coll Surg 2008;207:914-21.
59. Patel HS, Silver AR, Levine T, et al. Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg 2010;97: 1716-21.
60. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1, 000 patients. Medicine (Baltimore) 2003;82:299-308.
61. Moss KE, Ioannou Y, Sultan SM, et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002; 61:409-13.
62. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005;52: 1481-90.
63. Dey D, Kenu E, Isenberg DA. Cancer complicating systemic lupus erythematosus-A dichotomy emerging from a nested case-control study. Lupus 2013;22:919-27.
64. Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: A long-Term follow-up study in a Danish cohort. Arthritis Rheum 2011;63:3032-7.
65. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer 2000;83:89-90.
66. Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn's disease. Ann Surg 1984;199:348-50.
67. Slesser AA, Bhangu A, Bower M, et al. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol 2013;22:230-7.
68. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009;58:1152-67.
69. Morton LM, Curtis RE, Linet MS, et al. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol 2010;28:4935-44.
70. Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: A prospective population-based study. Lancet Oncol 2007;8:311-6.
71. Evans HS, Newnham A, Hodgson SV, et al. Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. Gynecol Oncol 2003;90:131-6.
72. Saleem AM, Paulus JK, Shapter AP, et al. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol 2011;117:643-9.
73. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104, 760 survivors of cervical cancer: evaluation of long-Term risk. J Natl Cancer Inst 2007;99:1634-43.
74. Jimenez W, Paszat L, Kupets R, et al. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol 2009;114: 395-8.
75. Eckert L. Screening for anal dysplasia in women with cervical, vaginal, or vulvar dysplasia: yes, no, maybe? Obstet Gynecol 2010; 116:566-7.
76. Park IU, Ogilvie JW Jr, Anderson KE, et al. Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009;114:399-403.
77. Santoso JT, Long M, Crigger M, et al. Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia. Obstet Gynecol 2010;116: 578-82.
78. Lamme J, Pattaratornkosohn T, Mercado-Abadie J, et al. Concurrent anal human papillomavirus and abnormal anal cytology in women with known cervical dysplasia. Obstet Gynecol 2014;124((2 Pt 1)):242-8.
79. Scholefield JH, Hickson WG, Smith JH, et al. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;340:1271-3.
80. Heraclio Sde A, Souza AS, Pinto FR, et al. Agreement between methods for diagnosing HPV-induced anal lesions in women with cervical neoplasia. Acta Cytol 2011;55:218-24.
81. Crawford R, Grignon AL, Kitson S, et al. High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer 2011;11:473.
82. Valari O, Koliopoulos G, Karakitsos P, et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol 2011; 122:505-8.
83. Darragh TM, Berry JM, Jay N, et al. Anal Disease. In: Apgar BS, Brotzman GL, Spitzer M, eds. Colposcopy: Principles and Practice. 2nd ed. Philadelphia: Saunders Elsevier; 2008:451-81.
84. Arain S, Walts AE, Thomas P, et al. The anal Pap smear: cytomorphology of squamous intraepithelial lesions. Cytojournal 2005;2:4.
85. Garcia FU, Haber MM, Butcher J, et al. Increased sensitivity of anal cytology in evaluation of internal compared with external lesions. Acta Cytol 2007;51:893-9.
86. Calore EE, Nadal SR, Manzione CR, et al. Anal cytology in patients with AIDS. Diagn Cytopathol 2010;38:260-3.
87. Gage JC, Ghosh A, Borgonovo S, et al. A comparison of Dacron versus flocked nylon swabs for anal cytology specimen collection. Acta Cytol 2011;55:364-7.
88. Wiley DJ, Hsu H, Bolan R, et al. Comparison of 2 anal cytology protocols to predict high-grade anal intraepithelial neoplasia. J Low Genit Tract Dis 2013;17:414-24.
89. Cranston RD, Darragh TM, Holly EA, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr (1999) 2004;36:915-20.
90. Lampinen TM, Miller ML, Chan K, et al. Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal 2006;3:4.
91. Chin-Hong PV, Berry JM, Cheng SC, et al. Comparison of patient-And clinician-collected anal cytology samples to screen for human papillomavirus-Associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008;149:300-6.
92. Gilbert M, Kwag M, Mei W, et al. Feasibility of incorporating self-collected rectal swabs into a community venue-based survey to measure the prevalence of HPV infection in men who have sex with men. Sex Transm Dis 2011;38:964-9.
93. Darragh TM, Jay N, Tupkelewicz BA, et al. Comparison of conventional cytologic smears and ThinPrep preparations from the anal canal. Acta Cytol 1997;41:1167-70.
94. Sherman ME, Friedman HB, Busseniers AE, et al. Cytologic diagnosis of anal intraepithelial neoplasia using smears and Cytyc Thin-Preps. Mod Pathol 1995;8:270-4.
95. Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology. New York: Springer; 2004.
96. Darragh T, Birdsong G, Luff RD, et al. Anal-Rectal Cytology. In: RSolomon DN, eds. The Bethesda System for Reporting Cervical Cytology. New York: Springer; 2004:169-75.
97. Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:415-22.
98. Vajdic CM, Anderson JS, Hillman RJ, et al. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect 2005;81:415-8.
99. Roberts JM, Thurloe J, Ekman D, et al., Farnsworth AobotSst. The value of transformation zone cells in cytological detection of anal high grade squamous intraepithelial lesions (HSIL). Poster presented at HPV 2014, 29th International Papillomavirus Conference, August 21-25, 2014, Seattle, Washington, USA .
100. Patarapadungkit N, Koonmee S, Pasatung E, et al. Anal cancer screening by modified liquid-based cytology in an HIV clinic. Asian Pac J Cancer Prev 2012;13:4487-90.
101. Bean SM, Chhieng DC. Anal-rectal cytology: A review. Diagn Cytopathol 2010;38:538-46.
102. FriedlanderMA, Stier E, Lin O. Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic, and histologic correlation. Cancer 2004;102:19-26.
103. Darragh TM, Winkler B, Souers RJ, et al. Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology. Arch Pathol Lab Med 2013;137:1550-4.
104. Lytwyn A, Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103: 1447-56.
105. Darragh TM, Tokugawa D, Castle PE, et al. Interrater agreement of anal cytology. Cancer Cytopathol 2013;121:72-8.
106. Roberts JM, Thurloe JK. Comparison of the performance of anal cytology and cervical cytology as screening tests. Sex Health 2012;9:568-73.
107. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011;119:5-19.
108. Chiao EY, Giordano TP, Palefsky JM, et al. Screening HIV-infected individuals for anal cancer precursor lesions: A systematic review. Clin Infect Dis 2006;43:223-33.
109. Berry JM, Palefsky JM, Jay N, et al. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009;52:239-47.
110. Swedish KA, Lee EQ, Goldstone SE. The changing picture of high-grade anal intraepithelial neoplasia in men who have sex withmen: The effects of 10 years of experience performing high-resolution anoscopy. Dis Colon Rectum 2011;54:1003-7.
111. Betancourt EM, Wahbah MM, Been LC, et al. Anal cytology as a predictor of anal intraepithelial neoplasia in HIV-positive men and women. Diagn Cytopathol 2013;41:697-702.
112. Mathews WC, Cachay ER, Caperna J, et al. Estimating the accuracy of anal cytology in the presence of an imperfect reference standard. PLoS One 2010;5:e12284.
113. Palefsky JM. Practising high-resolution anoscopy. Sex Health 2012;9: 580-6.
114. Phanuphak N, Teeratakulpisarn N, Keelawat S, et al. Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men. PLoS One 2013;8:e78291.
115. Wentzensen N, Follansbee S, Borgonovo S, et al. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. Aids 2012;26:2185-92.
116. Sehnal B, Dusek L, Cibula D, et al. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. J Clin Virol 2014;59:18-23.
117. Bjorge T, Engeland A, Luostarinen T, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002;87:61-4.
118. Sundstrom K, Eloranta S, Sparen P, et al. Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidemiol Biomarkers Prev 2010;19: 2469-78.
119. Berry-Lawhorn JM, Chrobak D, Jay N, et al. Who is ready to screen for anal squamous intraepithelial lesions and why should they perform high-resolution anoscopy? Sex Transm Dis 2014;41:254-6.
120. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72.
121. Silvera R, Gaisa MM, Goldstone SE. Random biopsy during high-resolution anoscopy increases diagnosis of anal high-grade squamous intraepithelial lesions. J Acquir Immune Defic Syndr (1999) 2014;65:65-71.
122. Giraldo P, Jacyntho C, Costa C, et al. Prevalence of anal squamous intra-epithelial lesion in women presenting genital squamous intra-epithelial lesion. Eur J Obstet Gynecol Reprod Biol 2009; 142:73-5.
123. New York State Department of Public Health AIDS Institute. Clinical Guidelines: Neoplastic Complication of HIV Infection; Section V-Anal Dysplasia and Cancer. 2014; http://www.hivguidelines.org/clinicalguidelines/adults/neoplastic-complications-of-hiv-infection/#V. Accessed June 6, 2014.
124. Ong J, Chen M, Temple-Smith M, et al. The inside story. Physicians' views on digital ano-rectal examination for anal cancer screening of HIV positive men who have sex with men. J Med Screen 2013;20: 188-91.
125. Berry JM, Jay N, Cranston RD, et al. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer 2014;134: 1147-55.
126. Machalek DA, Grulich AE, Hillman RJ, et al. The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC public health 2013;13:946.